What is the ICD-10 (International Classification of Diseases, 10th Revision) coding for an HIV (Human Immunodeficiency Virus) patient presenting with right middle and lower lobe clustered nodules suggestive of an atypical fungal infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10 Coding for Right Middle and Lower Lobe Clustered Nodules Suggesting Atypical Fungal Infection in an HIV Patient

The appropriate ICD-10 code for an HIV patient with right middle and lower lobe clustered nodules suggestive of atypical fungal infection is B20 (HIV disease resulting in infectious and parasitic diseases) with B48.8 (Other specified mycoses) as a secondary code.

Primary Coding Considerations

  • HIV disease with opportunistic infection should be coded as B20 (HIV disease resulting in infectious and parasitic diseases) as the primary diagnosis 1
  • For the specific fungal manifestation, B48.8 (Other specified mycoses) should be used as a secondary code when the exact fungal pathogen has not been definitively identified but clinical presentation suggests an atypical fungal infection 1
  • The pulmonary nodular pattern is consistent with fungal infection in immunocompromised patients, particularly those with advanced HIV disease 1

Differential Diagnosis Considerations

  • Nodular pulmonary lesions in HIV patients may represent several different fungal pathogens:
    • Cryptococcosis (B45.0 for pulmonary cryptococcosis) - common in HIV patients with CD4+ counts <250 cells/μL 1, 2
    • Coccidioidomycosis (B38.0-B38.9) - particularly in endemic regions 1
    • Histoplasmosis (B39.0-B39.9) - common in certain geographic regions 1
    • Nontuberculous mycobacterial infection (A31.0) - can present with nodular bronchiectatic pattern 1

Clinical Context for Coding

  • HIV patients with CD4+ counts <250 cells/μL are at higher risk for fungal infections, which should inform coding decisions 1
  • The presence of clustered nodules in the right middle and lower lobes is characteristic of certain fungal infections in immunocompromised hosts 1
  • Without definitive identification of the specific fungal pathogen through culture or histopathology, the more general code B48.8 is appropriate 1

Coding Algorithm

  1. First, assign B20 as the primary diagnosis (HIV disease resulting in infectious and parasitic diseases)
  2. Then, assign the most specific secondary code based on available information:
    • If fungal pathogen is identified through culture or histopathology:
      • Cryptococcus → B45.0 (Pulmonary cryptococcosis)
      • Coccidioides → B38.2 (Pulmonary coccidioidomycosis)
      • Histoplasma → B39.2 (Pulmonary histoplasmosis)
    • If fungal pathogen is not identified but clinical presentation suggests fungal infection → B48.8 (Other specified mycoses) 1, 3
    • If radiographic findings suggest specific location → add appropriate code for right middle lobe (J98.4) and right lower lobe (J98.4) involvement 1

Important Considerations

  • Definitive diagnosis through bronchoscopy with bronchoalveolar lavage, transbronchial biopsy, or other diagnostic procedures may allow for more specific coding 1
  • The clinical presentation of fungal infections in HIV patients may be atypical, making specific diagnosis challenging without invasive procedures 4, 5
  • Treatment considerations should guide diagnostic workup, as different fungal infections require different antifungal regimens 2, 6

Common Pitfalls in Coding

  • Avoid coding only the pulmonary manifestation without acknowledging the underlying HIV disease 1
  • Do not use B37.0-B37.9 (candidiasis) codes unless there is specific evidence of Candida infection, as this is less commonly associated with pulmonary nodules 1
  • Avoid using tuberculosis codes (A15-A19) without microbiological confirmation, even though the presentation may appear similar 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Cryptococcosis in Immunocompromised Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Fungal infections in HIV/AIDS.

The Lancet. Infectious diseases, 2017

Research

Fungal infections in HIV-infected patients.

Seminars in cutaneous medicine and surgery, 1997

Research

Common superficial fungal infections in patients with AIDS.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1996

Research

Pulmonary fungal infections in HIV-infected persons.

Seminars in respiratory infections, 1993

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.